Weight

In the first large-scale head-to-head study, people taking Eli Lilly's diabetes drug Munjaro lost significantly more weight than those taking Novo Nordisk's Ozempic, but side effects, withdrawal rates, and effects …

Delhi Water Minister Atish Marlena, who was on an indefinite hunger strike over water scarcity in the national capital, was admitted to Lok Nayak Jai Prakash (LNJP) Hospital on June …

Content oversight and quality assurance provided by Norcal Community Media. Norcal Community Media advertising leadership oversees sponsored, native, and paid content on this platform, ensuring its quality, relevance, and helpfulness …

Mounjaro (tirzepatide) is a once-weekly injection that helps people with type 2 diabetes manage their blood sugar levels. it was first approved Approved by the U.S. Food and Drug Administration …

A diabetes drug called tirzepatide is showing promising results for patients looking to lose weight. NBC news medical contributor …

ethics statement All procedures were performed in accordance with the guidelines and regulations of the University of Miyazaki. This study was also conducted in accordance with his NIH Guidelines for …

At a glance Bariatric surgery helped patients with type 2 diabetes improve their blood sugar control years later compared to medical and lifestyle interventions. The results of this study support …

Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. The main risk factor for type 2 diabetes is being overweight or obese, so …

Research Highlights: Three independent, preliminary research studies have found that new Type 2 diabetes and weight-loss medications are often not prescribed or provided to patients as needed. One …

Zepbound is a prescription drug Approved in 2023 Used by the U.S. Food and Drug Administration (FDA) for chronic weight management. Can Zepbound help you lose weight? And how effective …